Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Assets: 2020-2025

Historic Assets for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $834.3 million.

  • Cellebrite DI's Assets rose 32.59% to $834.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $834.3 million, marking a year-over-year increase of 32.59%. This contributed to the annual value of $690.6 million for FY2024, which is 29.59% up from last year.
  • Cellebrite DI's Assets amounted to $834.3 million in Q3 2025, which was up 5.96% from $787.4 million recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's Assets peaked at $834.3 million during Q3 2025, and registered a low of $315.1 million during Q3 2021.
  • Its 3-year average for Assets is $598.7 million, with a median of $556.6 million in 2024.
  • Its Assets has fluctuated over the past 5 years, first dropped by 6.75% in 2021, then surged by 41.47% in 2025.
  • Cellebrite DI's Assets (Quarterly) stood at $339.8 million in 2021, then rose by 18.69% to $403.3 million in 2022, then surged by 32.13% to $532.9 million in 2023, then increased by 29.59% to $690.6 million in 2024, then spiked by 32.59% to $834.3 million in 2025.
  • Its Assets stands at $834.3 million for Q3 2025, versus $787.4 million for Q2 2025 and $709.9 million for Q1 2025.